| Primary |
| Psoriatic Arthropathy |
42.9% |
| Psoriasis |
21.4% |
| Rheumatoid Arthritis |
14.3% |
| Myalgia |
7.1% |
| Pain |
7.1% |
| Rheumatic Disorder |
7.1% |
|
| Breast Cancer |
22.2% |
| Agranulocytosis |
11.1% |
| Hepatic Enzyme Increased |
11.1% |
| Psychotic Disorder |
11.1% |
| Rash |
11.1% |
| Rheumatoid Arthritis |
11.1% |
| Tongue Disorder |
11.1% |
| Viith Nerve Paralysis |
11.1% |
|
| Secondary |
| Product Used For Unknown Indication |
40.0% |
| Rheumatoid Arthritis |
31.4% |
| Hypertension |
5.1% |
| Acute Lymphocytic Leukaemia |
3.8% |
| Osteoporosis |
2.5% |
| Pain |
2.4% |
| Polyarthritis |
2.1% |
| Prophylaxis |
2.0% |
| Psoriatic Arthropathy |
1.9% |
| B-cell Lymphoma |
1.2% |
| Vomiting |
1.0% |
| Cardiac Failure |
0.9% |
| Diabetes Mellitus |
0.9% |
| Juvenile Arthritis |
0.9% |
| Diffuse Large B-cell Lymphoma |
0.7% |
| Oedema Peripheral |
0.7% |
| Prophylaxis Against Graft Versus Host Disease |
0.7% |
| Central Nervous System Lymphoma |
0.6% |
| Coronary Artery Disease |
0.6% |
| Depression |
0.6% |
|
| Hepatitis Cholestatic |
14.5% |
| Shoulder Operation |
10.1% |
| Varicose Vein |
8.7% |
| Rheumatoid Arthritis |
7.2% |
| Pruritus |
5.8% |
| Thrombocytopenia |
5.8% |
| Rash |
4.3% |
| Uterine Leiomyoma |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Vertigo |
4.3% |
| Weight Decreased |
4.3% |
| Arthritis Bacterial |
2.9% |
| Gastric Mucosal Lesion |
2.9% |
| Malaise |
2.9% |
| Metastatic Bronchial Carcinoma |
2.9% |
| Peritonitis |
2.9% |
| Psoriatic Arthropathy |
2.9% |
| Respiratory Failure |
2.9% |
| Septic Shock |
2.9% |
| Squamous Cell Carcinoma |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.4% |
| Rheumatoid Arthritis |
34.6% |
| Drug Use For Unknown Indication |
5.0% |
| Psoriatic Arthropathy |
4.1% |
| Hypertension |
3.2% |
| Psoriasis |
2.0% |
| Crohn's Disease |
1.9% |
| Osteoporosis |
1.9% |
| Pain |
1.9% |
| Prophylaxis |
1.6% |
| Prophylaxis Against Graft Versus Host Disease |
1.0% |
| Vitamin Supplementation |
0.9% |
| Osteoporosis Prophylaxis |
0.8% |
| Depression |
0.8% |
| Ankylosing Spondylitis |
0.7% |
| Blood Pressure |
0.7% |
| Diabetes Mellitus |
0.7% |
| Polyarthritis |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Gastric Disorder |
0.7% |
|
| Pneumonia |
11.2% |
| Psoriasis |
8.2% |
| Urinary Tract Infection |
8.2% |
| Transaminases Increased |
7.3% |
| Injection Site Pain |
5.6% |
| Rheumatoid Arthritis |
5.6% |
| Death |
5.2% |
| Joint Arthroplasty |
5.2% |
| Vomiting |
5.2% |
| Sepsis |
4.7% |
| Upper Respiratory Tract Infection |
4.7% |
| Weight Decreased |
4.7% |
| Pain |
3.9% |
| Thrombosis |
3.4% |
| West Nile Viral Infection |
3.4% |
| Infusion Related Reaction |
3.0% |
| Renal Failure |
3.0% |
| Weight Increased |
3.0% |
| Pyrexia |
2.6% |
| Arthralgia |
2.1% |
|
| Interacting |
| Hypertension |
20.5% |
| Rheumatoid Arthritis |
15.4% |
| Tachyarrhythmia |
15.4% |
| Acute Lymphocytic Leukaemia |
10.3% |
| Epilepsy |
5.1% |
| Hyperlipidaemia |
5.1% |
| Immunosuppressant Drug Therapy |
5.1% |
| Iron Deficiency |
5.1% |
| Osteoporosis |
5.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.1% |
| Restlessness |
5.1% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
|
| Drug Level Increased |
40.0% |
| Transaminases Increased |
40.0% |
| Thrombocytopenia |
20.0% |
|
